Home RxNorm 1928864 1.7 ML articaine hydrochloride 40 MG/ML / epinephrine bitartrate 0.018 MG/ML Cartridge [Ultacan] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1928864
RxNorm name 1.7 ML articaine hydrochloride 40 MG/ML / epinephrine bitartrate 0.018 MG/ML Cartridge [Ultacan]
Display name ULTACAN (Injectable)
Full name 1.7 ML articaine hydrochloride 40 MG/ML / epinephrine bitartrate 0.018 MG/ML Cartridge [Ultacan]
Term type SBD
Status Active
Strength 40-0.018 mg/ml
Dose form Cartridge 1.7 ml
Route Injectable
Updated 2026-11-06 11:39:28 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 082017
Active start 082017
Multiple ingredient YES
Branded YES Ingredients And Strength# Derived Ingredient Concepts# RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 4 matching rows.
NDC11, Source, Active table NDC11 Source Active 52120010000 rxnav_ndcs yes 52120010001 rxnav_historical 52120010005 rxnav_historical 52120010010 rxnav_historical
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective e005e3da-142d-4eba-a0c0-35e05b234130 Ultacan forte 40 MG / 1:100,000 in 1.7 ML Cartridge [PSN] · 1.7 ML articaine hydrochloride 40 MG/ML / epinephrine bitartrate 0.018 MG/ML Cartridge [Ultacan] [SBD] · Ultacan 40 MG / 0.018 MG per 1.7 ML Cartridge [SY] · Ultacan 40 MG / 1:100,000 per 1.7 ML Cartridge [SY] 4 1 These highlights do not include all the information needed to use Ultacan® and Ultacan® forte safely and effectively. See full prescribing information for Ultacan® and Ultacan® forte. Ultacan® and Ultacan® forte (Articaine HCl 4% and epinephrine Injection, USP); Intraoral Submucosal Injection Articaine hydrochloride 4% and epinephrine 1:200,000 Articaine hydrochloride 4% and epinephrine 1:100,000 Initial U.S. Approval: 2000 20170720
Recently Linked DailyMed Labels# Set ID, Title, Manufacturer table Set ID Title Manufacturer Effective e005e3da-142d-4eba-a0c0-35e05b234130 These highlights do not include all the information needed to use Ultacan® and Ultacan® forte safely and effectively. See full prescribing information for Ultacan® and Ultacan® forte. Ultacan® and Ultacan® forte (Articaine HCl 4% and epinephrine Injection, USP); Intraoral Submucosal Injection Articaine hydrochloride 4% and epinephrine 1:200,000 Articaine hydrochloride 4% and epinephrine 1:100,000 Initial U.S. Approval: 2000 HANSAmed, Inc. | Sanofi-Aventis Deutschland GmbH 20170720
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC C01CA Adrenergic and dopaminergic agents ATC1-4 epinephrine ATC R03AA Alpha- and beta-adrenoreceptor agonists ATC1-4 epinephrine ATC N01BB Amides ATC1-4 articaine ATC B02BC Local hemostatics ATC1-4 epinephrine ATC A01AD Other agents for local oral treatment ATC1-4 epinephrine ATC S01EA Sympathomimetics in glaucoma therapy ATC1-4 epinephrine ATC R01AA Sympathomimetics, plain ATC1-4 epinephrine FDASPL D000577 Amides CHEM has_chemical_structure articaine FDASPL D002395 Catecholamines CHEM has_chemical_structure epinephrine FDASPL N0000175552 alpha-Adrenergic Agonist EPC has_epc epinephrine FDASPL N0000175682 Amide Local Anesthetic EPC has_epc articaine FDASPL N0000175555 beta-Adrenergic Agonist EPC has_epc epinephrine FDASPL N0000175570 Catecholamine EPC has_epc epinephrine FDASPL N0000000209 Adrenergic alpha-Agonists MOA has_moa epinephrine FDASPL N0000000245 Adrenergic beta-Agonists MOA has_moa epinephrine FDASPL N0000175976 Local Anesthesia PE has_pe articaine MEDRT D002355 Carticaine CHEM has_ingredient articaine MEDRT D004837 Epinephrine CHEM has_ingredient epinephrine MEDRT D004837 Epinephrine CHEM has_ingredient epinephrine bitartrate MEDRT D000402 Airway Obstruction DISEASE may_treat epinephrine MEDRT D000402 Airway Obstruction DISEASE may_treat epinephrine bitartrate MEDRT D000707 Anaphylaxis DISEASE may_treat epinephrine MEDRT D000707 Anaphylaxis DISEASE may_treat epinephrine bitartrate MEDRT D001145 Arrhythmias, Cardiac DISEASE ci_with epinephrine bitartrate MEDRT D001145 Arrhythmias, Cardiac DISEASE ci_with epinephrine MEDRT D001919 Bradycardia DISEASE may_treat epinephrine MEDRT D001919 Bradycardia DISEASE may_treat epinephrine bitartrate MEDRT D001986 Bronchial Spasm DISEASE may_treat epinephrine MEDRT D001986 Bronchial Spasm DISEASE may_treat epinephrine bitartrate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with epinephrine MEDRT D004342 Drug Hypersensitivity DISEASE ci_with epinephrine bitartrate MEDRT D015812 Glaucoma, Angle-Closure DISEASE ci_with epinephrine MEDRT D015812 Glaucoma, Angle-Closure DISEASE ci_with epinephrine bitartrate MEDRT D005902 Glaucoma, Open-Angle DISEASE may_treat epinephrine MEDRT D005902 Glaucoma, Open-Angle DISEASE may_treat epinephrine bitartrate MEDRT D006323 Heart Arrest DISEASE may_treat epinephrine MEDRT D006323 Heart Arrest DISEASE may_treat epinephrine bitartrate MEDRT D006327 Heart Block DISEASE may_treat epinephrine bitartrate MEDRT D006327 Heart Block DISEASE may_treat epinephrine MEDRT D006967 Hypersensitivity DISEASE ci_with articaine hydrochloride MEDRT D006967 Hypersensitivity DISEASE ci_with articaine MEDRT D007022 Hypotension DISEASE may_treat epinephrine bitartrate MEDRT D007022 Hypotension DISEASE may_treat epinephrine MEDRT D010146 Pain DISEASE may_treat articaine hydrochloride MEDRT D010146 Pain DISEASE may_prevent articaine hydrochloride MEDRT D010146 Pain DISEASE may_prevent articaine MEDRT D010146 Pain DISEASE may_treat articaine MEDRT D012772 Shock, Septic DISEASE may_treat epinephrine bitartrate MEDRT D012772 Shock, Septic DISEASE may_treat epinephrine MEDRT D017180 Tachycardia, Ventricular DISEASE may_treat epinephrine MEDRT D017180 Tachycardia, Ventricular DISEASE may_treat epinephrine bitartrate MEDRT D014693 Ventricular Fibrillation DISEASE may_treat epinephrine MEDRT D014693 Ventricular Fibrillation DISEASE may_treat epinephrine bitartrate MEDRT N0000000209 Adrenergic alpha-Agonists MOA has_moa epinephrine MEDRT N0000000209 Adrenergic alpha-Agonists MOA has_moa epinephrine bitartrate MEDRT N0000009921 Adrenergic beta1-Agonists MOA has_moa epinephrine bitartrate MEDRT N0000009921 Adrenergic beta1-Agonists MOA has_moa epinephrine MEDRT N0000009922 Adrenergic beta2-Agonists MOA has_moa epinephrine bitartrate MEDRT N0000009922 Adrenergic beta2-Agonists MOA has_moa epinephrine MEDRT N0000000180 Sodium Channel Interactions MOA has_moa articaine MEDRT N0000000180 Sodium Channel Interactions MOA has_moa articaine hydrochloride MEDRT N0000008298 Arterial Vasoconstriction PE has_pe epinephrine bitartrate MEDRT N0000008298 Arterial Vasoconstriction PE has_pe epinephrine MEDRT N0000008322 Bronchodilation PE has_pe epinephrine bitartrate MEDRT N0000008322 Bronchodilation PE has_pe epinephrine MEDRT N0000009944 Decreased Intraocular Aqueous Secretion PE has_pe epinephrine MEDRT N0000009944 Decreased Intraocular Aqueous Secretion PE has_pe epinephrine bitartrate MEDRT N0000008889 Decreased Sensory-Somatic Nervous System Organized Electrical Activity PE has_pe articaine hydrochloride MEDRT N0000008889 Decreased Sensory-Somatic Nervous System Organized Electrical Activity PE has_pe articaine MEDRT N0000009014 Decreased Uterine Smooth Muscle Contraction or Tone PE has_pe epinephrine bitartrate MEDRT N0000009014 Decreased Uterine Smooth Muscle Contraction or Tone PE has_pe epinephrine MEDRT N0000009070 Hemostasis Alteration PE has_pe epinephrine bitartrate MEDRT N0000009070 Hemostasis Alteration PE has_pe epinephrine MEDRT N0000178478 Increased Blood Pressure PE has_pe epinephrine bitartrate MEDRT N0000178478 Increased Blood Pressure PE has_pe epinephrine MEDRT N0000009808 Positive Chronotropy PE has_pe epinephrine MEDRT N0000009808 Positive Chronotropy PE has_pe epinephrine bitartrate MEDRT N0000009809 Positive Inotropy PE has_pe epinephrine bitartrate MEDRT N0000009809 Positive Inotropy PE has_pe epinephrine MEDRT N0000009820 Pupillary Dilation PE has_pe epinephrine bitartrate MEDRT N0000009820 Pupillary Dilation PE has_pe epinephrine
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 40 MG/ML / 0.018 MG/ML (expressed as epinephrine bitartrate) ATTRIBUTES GENERAL_CARDINALITY MULTI ATTRIBUTES HUMAN_DRUG US ATTRIBUTES QUANTITY 1.7 ML ATTRIBUTES RXNAV_HUMAN_DRUG US CODES ANDA ANDA201750 NAMES Prescribable Synonym Ultacan forte 40 MG / 1:100,000 in 1.7 ML Cartridge NAMES Tallman Synonym 1.7 ML articaine hydrochloride 40 MG/ML / EPINEPHrine bitartrate 0.018 MG/ML Cartridge [Ultacan] SOURCES Source Metathesaurus FDA Structured Product Labels